PortfoliosLab logoPortfoliosLab logo
HALO vs. QUAL
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

HALO vs. QUAL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Halozyme Therapeutics, Inc. (HALO) and iShares MSCI USA Quality Factor ETF (QUAL). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, HALO achieves a 3.74% return, which is significantly lower than QUAL's 8.80% return. Over the past 10 years, HALO has outperformed QUAL with an annualized return of 21.91%, while QUAL has yielded a comparatively lower 14.27% annualized return.


HALO

1D
5.34%
1M
8.13%
YTD
3.74%
6M
7.98%
1Y
30.97%
3Y*
27.65%
5Y*
12.08%
10Y*
21.91%

QUAL

1D
-0.07%
1M
4.62%
YTD
8.80%
6M
8.86%
1Y
21.68%
3Y*
19.66%
5Y*
11.96%
10Y*
14.27%
*Multi-year figures are annualized to reflect compound growth (CAGR)

HALO vs. QUAL - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
HALO
Halozyme Therapeutics, Inc.
3.74%40.77%29.36%-35.04%41.51%-5.85%140.89%21.19%-27.79%105.06%
QUAL
iShares MSCI USA Quality Factor ETF
8.80%12.65%22.29%30.88%-20.50%26.94%17.04%33.89%-5.70%22.26%

Correlation

The correlation between HALO and QUAL is 0.27, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.27

Correlation (3Y)
Calculated over the trailing 3-year period

0.28

Correlation (5Y)
Calculated over the trailing 5-year period

0.37

Correlation (10Y)
Calculated over the trailing 10-year period

0.40

Correlation (All Time)
Calculated using the full available price history since Jul 19, 2013

0.41

The correlation between HALO and QUAL shifts across timeframes, from 0.27 (1 year) to 0.41 (all time), reflecting how their relationship changes across market environments.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

HALO vs. QUAL — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HALO
HALO Risk / Return Rank: 6666
Overall Rank
HALO Sharpe Ratio Rank: 7272
Sharpe Ratio Rank
HALO Sortino Ratio Rank: 6666
Sortino Ratio Rank
HALO Omega Ratio Rank: 6464
Omega Ratio Rank
HALO Calmar Ratio Rank: 6565
Calmar Ratio Rank
HALO Martin Ratio Rank: 6262
Martin Ratio Rank

QUAL
QUAL Risk / Return Rank: 5353
Overall Rank
QUAL Sharpe Ratio Rank: 5353
Sharpe Ratio Rank
QUAL Sortino Ratio Rank: 5353
Sortino Ratio Rank
QUAL Omega Ratio Rank: 5151
Omega Ratio Rank
QUAL Calmar Ratio Rank: 4848
Calmar Ratio Rank
QUAL Martin Ratio Rank: 6060
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

HALO vs. QUAL - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Halozyme Therapeutics, Inc. (HALO) and iShares MSCI USA Quality Factor ETF (QUAL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


HALOQUALDifference
Sharpe ratioReturn per unit of total volatility

-0.81

Sortino ratioReturn per unit of downside risk

-1.07

Omega ratioGain probability vs. loss probability

1.19

1.32

-0.13

Calmar ratioReturn relative to maximum drawdown

1.29

2.41

-1.12

Martin ratioReturn relative to average drawdown

2.47

11.00

-8.52

HALO vs. QUAL - Sharpe Ratio Comparison

The current HALO Sharpe Ratio is 1.04, which is lower than the QUAL Sharpe Ratio of 1.84. The chart below compares the historical Sharpe Ratios of HALO and QUAL, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


HALOQUALDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.04

1.84

-0.81

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.31

0.69

-0.39

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.51

0.79

-0.28

Sharpe Ratio (All Time)

Calculated using the full available price history

0.23

0.80

-0.57

Drawdowns

HALO vs. QUAL - Drawdown Comparison

The maximum HALO drawdown since its inception was -74.26%, which is greater than QUAL's maximum drawdown of -34.06%. Use the drawdown chart below to compare losses from any high point for HALO and QUAL.


Loading charts...

Drawdown Indicators


HALOQUALDifference

Max Drawdown

Largest peak-to-trough decline

-74.26%

-34.06%

-40.20%

Max Drawdown (1Y)

Largest decline over 1 year

-24.13%

-9.03%

-15.10%

Max Drawdown (3Y)

Largest decline over 3 years

-33.92%

-18.00%

-15.92%

Max Drawdown (5Y)

Largest decline over 5 years

-49.06%

-28.23%

-20.83%

Max Drawdown (10Y)

Largest decline over 10 years

-49.06%

-34.06%

-15.00%

Current Drawdown

Current decline from peak

-14.05%

-0.16%

-13.89%

Average Drawdown

Average peak-to-trough decline

-31.91%

-4.11%

-27.80%

Ulcer Index

Depth and duration of drawdowns from previous peaks

12.55%

1.98%

+10.57%

Volatility

HALO vs. QUAL - Volatility Comparison

Halozyme Therapeutics, Inc. (HALO) has a higher volatility of 11.55% compared to iShares MSCI USA Quality Factor ETF (QUAL) at 2.51%. This indicates that HALO's price experiences larger fluctuations and is considered to be riskier than QUAL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


HALOQUALDifference

Volatility (1M)

Calculated over the trailing 1-month period

11.55%

2.51%

+9.04%

Volatility (6M)

Calculated over the trailing 6-month period

24.29%

9.03%

+15.26%

Volatility (1Y)

Calculated over the trailing 1-year period

30.34%

11.83%

+18.51%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

39.53%

17.33%

+22.20%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

42.91%

18.10%

+24.81%

Dividends

HALO vs. QUAL - Dividend Comparison

HALO has not paid dividends to shareholders, while QUAL's dividend yield for the trailing twelve months is around 0.88%.


PositionTTM20252024202320222021202020192018201720162015
HALO
Halozyme Therapeutics, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
QUAL
iShares MSCI USA Quality Factor ETF
0.88%0.94%1.02%1.23%1.59%1.20%1.39%1.60%2.00%1.76%1.96%1.63%

Frequently Asked Questions


HALO and QUAL have a correlation of 0.27, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

HALO has higher volatility (11.55%) compared to QUAL (2.51%). In terms of maximum drawdown, HALO dropped -74.26% vs QUAL's -34.06%.

QUAL currently has the higher Sharpe Ratio (1.84 vs 1.04), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for HALO and QUAL

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer